PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-44.75%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-44.75%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
282.29%
Positive EBIT growth while XRF.AX is negative. John Neff might see a substantial edge in operational management.
282.29%
Positive operating income growth while XRF.AX is negative. John Neff might view this as a competitive edge in operations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.77%
Share count expansion well above XRF.AX's 1.21%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
5.77%
Diluted share count expanding well above XRF.AX's 1.24%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-28.49%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-26.96%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-93.18%
Negative 10Y revenue/share CAGR while XRF.AX stands at 151.40%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-93.18%
Negative 5Y CAGR while XRF.AX stands at 74.52%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
359.22%
3Y revenue/share CAGR above 1.5x XRF.AX's 49.22%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
38.59%
10Y OCF/share CAGR under 50% of XRF.AX's 132.15%. Michael Burry would worry about a persistent underperformance in cash creation.
38.59%
Below 50% of XRF.AX's 1139.05%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
23.81%
3Y OCF/share CAGR under 50% of XRF.AX's 144.47%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-100.00%
Negative 10Y net income/share CAGR while XRF.AX is at 198.79%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-100.00%
Negative 5Y net income/share CAGR while XRF.AX is 195.12%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.